Dr. Luana Tanaka is a member of the Concord Programme, which is dedicated to the global surveillance of cancer-survival data, and has published an article in the renowned specialist periodical "The Lancet". With an Impact Factor of 53, this specialist periodical makes use of a peer-reviewing…
[read more]